Recent Posts
- ‘Protein printing’ AbSci secures $125M crossover as it expands synthetic biology ambitions
- AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform
- L7 Informatics Raises $13M in Series B Financing
- ReForm taps ex-Genzyme exec to lead subcutaneous delivery strategy
- 8 Female Venture Capital Investors To Watch In 2021